Telbivudine: A new treatment for chronic hepatitis B.
[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B.]

Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future
Telbivudine: A new treatment for chronic hepatitis B.
Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis with Telbivudine or Adefovir
Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment
Telbivudine for the management of chronic hepatitis B virus infection.
[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B.]
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.
[Current data on the treatment of chronic hepatitis B.]
Oral antivirals for chronic hepatitis B.
[New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities]
Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
Customizing the management of chronic hepatitis B virus infection
Improving outcomes for patients with chronic hepatitis B.
[Advances in the treatment of hepatitis B]
Treatment paradigms on hepatitis B e antigen-negative chronic hepatitis B patients
Telbivudine for the treatment of chronic hepatitis B.
Telbivudine: a new option for the treatment of chronic hepatitis B.
Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.
New and emerging treatment of chronic hepatitis B.
Improving outcomes for patients with chronic hepatitis B.
Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.
Diagnosis and treatment of chronic hepatitis B: an update.
Enantio-selectivity of human nucleoside monophosphate kinases.
